Skip to main content

Tailoring CMV Prophylaxis Based on a CMV T Cell Immunity Panel Assay in Kidney Transplant Patients

This interesting presentation will review The University of Nebraska's Kidney Transplant program's strategy of using CMV inSIGHT T Cell Immunity testing to serially monitor high risk kidney transplant patients to evaluate if prophylaxis could be discontinued early. Dr. Clifford Miles will review data originally presented at the Cutting Edge of Transplantation earlier this year. Dr. Miles is the Medical Director of Kidney and Pancreas Transplant at the University of Nebraska's Medical Center and Associate Professor, Nephrology Division at UNMC's college of medicine. 

Including a special Q&A between authors of the study

Length of Presentation: 48 minutes

Presented by: 

  • Dr. Clifford Miles, MD, FAST
    • Associate Professor
      Internal Medicine-Nephrology
      University of Nebraska Medical Center
    • Medical Director
      Kidney & Pancreas Transplantation
      Nebraska Medicine


Back to top